{"product_id":"300725sz-marketing-mix","title":"PharmaBlock Sciences , Inc. (300725.SZ): Marketing Mix Analysis","description":"\u003cp\u003eIn the fast-evolving world of pharmaceuticals, PharmaBlock Sciences (Nanjing), Inc. stands out as a key player through its strategic marketing mix—the four P’s of product, place, promotion, and price. From bespoke synthesis services to a robust global distribution network, this company adeptly navigates the complexities of drug discovery and development. Curious about how their tailored pricing strategies, dynamic promotional activities, and strategic location bolster their competitive edge? Dive in to discover the intricacies that set PharmaBlock apart in the bustling pharmaceutical landscape!\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003ePharmaBlock Sciences (Nanjing), Inc. - Marketing Mix: Product\u003c\/h2\u003e\n\n### Custom Synthesis Services\nPharmaBlock offers custom synthesis services that cater to the specific needs of pharmaceutical companies, biopharmaceuticals, and research institutions. As of 2023, the global custom synthesis market was valued at approximately $14.2 billion, with an expected compound annual growth rate (CAGR) of 6.5% from 2023 to 2030. PharmaBlock’s portfolio includes:\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eService Category\u003c\/th\u003e\n    \u003cth\u003eDescription\u003c\/th\u003e\n    \u003cth\u003eAnnual Revenue (2023)\u003c\/th\u003e\n    \u003cth\u003eMarket Share (%)\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCustom Peptide Synthesis\u003c\/td\u003e\n    \u003ctd\u003eSynthesis of peptides for drug development and research\u003c\/td\u003e\n    \u003ctd\u003e$5 million\u003c\/td\u003e\n    \u003ctd\u003e3.5%\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eSmall Molecule Synthesis\u003c\/td\u003e\n    \u003ctd\u003eProduction of small molecules for clinical trials\u003c\/td\u003e\n    \u003ctd\u003e$10 million\u003c\/td\u003e\n    \u003ctd\u003e2.5%\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eComplex Organic Molecule Synthesis\u003c\/td\u003e\n    \u003ctd\u003eCustomized solutions for complex organic compounds\u003c\/td\u003e\n    \u003ctd\u003e$7 million\u003c\/td\u003e\n    \u003ctd\u003e2.0%\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n### Medicinal Chemistry Solutions\nPharmaBlock specializes in medicinal chemistry, providing expert services that assist in drug discovery and optimization. According to industry reports, the medicinal chemistry market was valued at approximately $3.4 billion in 2022 and is projected to reach $5.5 billion by 2029, growing at a CAGR of 7.0%. Their offerings include:\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eService Type\u003c\/th\u003e\n    \u003cth\u003eScope of Work\u003c\/th\u003e\n    \u003cth\u003eCost per Project (Average)\u003c\/th\u003e\n    \u003cth\u003eClient Segments\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eHit Identification\u003c\/td\u003e\n    \u003ctd\u003eScreening and identifying potential drug candidates\u003c\/td\u003e\n    \u003ctd\u003e$150,000\u003c\/td\u003e\n    \u003ctd\u003ePharmaceuticals, Biotechs\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eLead Optimization\u003c\/td\u003e\n    \u003ctd\u003eRefining chemical compounds to enhance efficacy\u003c\/td\u003e\n    \u003ctd\u003e$250,000\u003c\/td\u003e\n    \u003ctd\u003ePharmaceuticals, Academic Institutions\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eADMET Profiling\u003c\/td\u003e\n    \u003ctd\u003eAnalyzing absorption, distribution, metabolism, excretion, and toxicity\u003c\/td\u003e\n    \u003ctd\u003e$50,000\u003c\/td\u003e\n    \u003ctd\u003ePharmaceuticals, Research Organizations\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n### Building Blocks for Drug Discovery\nPharmaBlock provides essential building blocks for drug discovery, including pharmaceutical intermediates, fragments, and scaffolds. The market for drug discovery building blocks is estimated to be around $2.7 billion in 2023, predicted to increase to $4.9 billion by 2030, with a CAGR of 9.4%. Key products include:\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eProduct Type\u003c\/th\u003e\n    \u003cth\u003eDescription\u003c\/th\u003e\n    \u003cth\u003eAnnual Units Sold\u003c\/th\u003e\n    \u003cth\u003eAverage Price per Unit\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003ePharmaceutical Intermediates\u003c\/td\u003e\n    \u003ctd\u003eCompound used in the intermediate steps of drug synthesis\u003c\/td\u003e\n    \u003ctd\u003e300,000 units\u003c\/td\u003e\n    \u003ctd\u003e$25\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eChemical Fragments\u003c\/td\u003e\n    \u003ctd\u003eSmall chemical compounds used in the early stages of drug discovery\u003c\/td\u003e\n    \u003ctd\u003e150,000 units\u003c\/td\u003e\n    \u003ctd\u003e$35\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eScaffolds\u003c\/td\u003e\n    \u003ctd\u003eCore structures used for further modifications\u003c\/td\u003e\n    \u003ctd\u003e200,000 units\u003c\/td\u003e\n    \u003ctd\u003e$40\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n### Specialty Chemicals\nPharmaBlock also manufactures specialty chemicals, tailored to meet specific industry requirements. The specialty chemicals market was valued at approximately $966 billion in 2022 and is forecasted to reach $1.2 trillion by 2026, with a CAGR of 7.0%. Their offerings in this area include:\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eChemical Type\u003c\/th\u003e\n    \u003cth\u003eApplications\u003c\/th\u003e\n    \u003cth\u003eMarket Demand (2023)\u003c\/th\u003e\n    \u003cth\u003eAverage Selling Price\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eReagents\u003c\/td\u003e\n    \u003ctd\u003eUsed in chemical synthesis and analysis\u003c\/td\u003e\n    \u003ctd\u003e1,000 metric tons\u003c\/td\u003e\n    \u003ctd\u003e$50\/kg\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eSolvents\u003c\/td\u003e\n    \u003ctd\u003eSolubilizing agents in various chemical processes\u003c\/td\u003e\n    \u003ctd\u003e2,000 metric tons\u003c\/td\u003e\n    \u003ctd\u003e$30\/kg\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCatalysts\u003c\/td\u003e\n    \u003ctd\u003eSubstances that increase the rate of chemical reactions\u003c\/td\u003e\n    \u003ctd\u003e500 metric tons\u003c\/td\u003e\n    \u003ctd\u003e$100\/kg\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\n### CRO and CMO Services\nPharmaBlock provides Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) services, facilitating comprehensive support for drug development. The global CRO market was valued at approximately $45 billion in 2023, while the CMO sector reached about $90 billion. Key metrics associated with PharmaBlock’s CRO and CMO services include:\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eService Type\u003c\/th\u003e\n    \u003cth\u003eService Description\u003c\/th\u003e\n    \u003cth\u003eMarket Share (%)\u003c\/th\u003e\n    \u003cth\u003eEstimated Revenue (2023)\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCRO Services\u003c\/td\u003e\n    \u003ctd\u003eResearch and development services for drug discovery\u003c\/td\u003e\n    \u003ctd\u003e2.5%\u003c\/td\u003e\n    \u003ctd\u003e$1.125 billion\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCMO Services\u003c\/td\u003e\n    \u003ctd\u003eManufacturing and quality control for pharmaceutical products\u003c\/td\u003e\n    \u003ctd\u003e2.0%\u003c\/td\u003e\n    \u003ctd\u003e$1.8 billion\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003ePharmaBlock Sciences (Nanjing), Inc. - Marketing Mix: Place\u003c\/h2\u003e\n\nPharmaBlock Sciences (Nanjing), Inc., headquartered in Nanjing, China, operates with a comprehensive global distribution network designed to facilitate the delivery of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) to clients across various regions.\n\n### Headquarters in Nanjing, China\nNanjing serves as a strategic hub, with the city being one of the most prominent centers for pharmaceutical research and development in China. The main office provides access to top-tier talent and infrastructure in the biotech sector.\n\n### Global Distribution Network\nPharmaBlock has established an extensive global distribution network. The company reports that it has partnerships with over 400 clients, spanning more than 40 countries. Specifically, the company aims to achieve a 30% increase in its international sales over the next fiscal year.\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eRegion\u003c\/th\u003e\n\u003cth\u003eNumber of Clients\u003c\/th\u003e\n\u003cth\u003e% of Total Sales\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003e150\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEurope\u003c\/td\u003e\n\u003ctd\u003e120\u003c\/td\u003e\n\u003ctd\u003e35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAsia Pacific\u003c\/td\u003e\n\u003ctd\u003e80\u003c\/td\u003e\n\u003ctd\u003e20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n### Collaborations with International Research Institutions\nPharmaBlock actively collaborates with prominent research institutions such as the Massachusetts Institute of Technology (MIT) and Stanford University. These partnerships enhance the company's research capabilities, allowing for innovative approaches to drug development and process optimization.\n\n### Regional Offices for Local Presence\nTo ensure effective market penetration, PharmaBlock has established regional offices in key markets such as the United States, Germany, and Japan. These offices facilitate localized service, ensuring that customers receive timely support. The U.S. office, for example, generated approximately $15 million in sales in 2022 alone.\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eOffice Location\u003c\/th\u003e\n\u003cth\u003eYear Established\u003c\/th\u003e\n\u003cth\u003eSales in 2022 (USD)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUnited States\u003c\/td\u003e\n\u003ctd\u003e2018\u003c\/td\u003e\n\u003ctd\u003e$15 million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGermany\u003c\/td\u003e\n\u003ctd\u003e2019\u003c\/td\u003e\n\u003ctd\u003e$10 million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJapan\u003c\/td\u003e\n\u003ctd\u003e2020\u003c\/td\u003e\n\u003ctd\u003e$8 million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n### E-commerce Platform for Global Reach\nPharmaBlock has developed a robust e-commerce platform aimed at enhancing its global reach. The platform allows clients to order products and access services seamlessly. In 2022, the e-commerce channel contributed to approximately 25% of the company's total sales revenue, amounting to $12.5 million.\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eYear\u003c\/th\u003e\n\u003cth\u003eE-commerce Sales (USD)\u003c\/th\u003e\n\u003cth\u003e% of Total Sales\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2022\u003c\/td\u003e\n\u003ctd\u003e$12.5 million\u003c\/td\u003e\n\u003ctd\u003e25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2021\u003c\/td\u003e\n\u003ctd\u003e$8 million\u003c\/td\u003e\n\u003ctd\u003e20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2020\u003c\/td\u003e\n\u003ctd\u003e$5 million\u003c\/td\u003e\n\u003ctd\u003e15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\nThe strategic placement of PharmaBlock Sciences in various markets, combined with effective logistical frameworks, ensures that the company maintains a competitive edge while maximizing customer convenience and satisfaction.\n\u003cbr\u003e\u003ch2\u003ePharmaBlock Sciences (Nanjing), Inc. - Marketing Mix: Promotion\u003c\/h2\u003e\n\nPharmaBlock Sciences engages in multifaceted promotional strategies to effectively communicate its offerings to the pharmaceutical industry. Below, details of each promotional avenue are outlined.\n\n### Attending Global Pharmaceutical Conferences\n\nPharmaBlock actively participates in major global pharmaceutical conferences. For instance, in 2023, the company attended events such as CPhI Worldwide, which attracted over 45,000 attendees and featured more than 2,500 exhibitors from around the world. The cost of attendance, including booth setup and promotional materials, ranged approximately from $30,000 to $100,000 per conference.\n\n### Participating in Industry Exhibitions\n\nThe participation in industry exhibitions is a cornerstone of PharmaBlock's marketing strategy. In 2022, they showcased products at the BIO International Convention, which hosted more than 15,000 attendees and 1,800 exhibitors. The expense for exhibiting, including travel and accommodation, was approximately $50,000 per event. The exhibitions provide a platform to generate leads and build relationships with potential clients.\n\n### Publishing Research in Scientific Journals\n\nPharmaBlock invests in publishing peer-reviewed research to enhance credibility and visibility. In 2022, the average cost of publishing articles in reputable journals was around $2,500, with some journals charging up to $5,000, depending on open access fees. The company published over 10 articles in scientific journals, leading to increased citation metrics, with some articles being cited over 150 times.\n\n### Collaborating with Academic Institutions\n\nPharmaBlock collaborates with various academic institutions to foster research and development. In 2023, they announced a partnership with Nanjing University to conduct R\u0026amp;D projects, costing approximately $200,000 annually. Collaborations often result in co-authored publications, joint patent applications, and greater outreach for both parties.\n\n### Digital Marketing Campaigns\n\nDigital marketing is a crucial component of PharmaBlock's promotional strategy. In 2023, the company allocated $300,000 to be used in various digital marketing initiatives including SEO, PPC, and content marketing. The campaigns targeted specific demographics resulting in a 25% increase in website traffic and a 15% increase in qualified leads.\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003ePromotional Activity\u003c\/th\u003e\n        \u003cth\u003eDetails\u003c\/th\u003e\n        \u003cth\u003eCost\u003c\/th\u003e\n        \u003cth\u003eImpact\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eGlobal Conferences\u003c\/td\u003e\n        \u003ctd\u003eCPhI Worldwide (2023)\u003c\/td\u003e\n        \u003ctd\u003e$30,000 - $100,000\u003c\/td\u003e\n        \u003ctd\u003e45,000 attendees\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eIndustry Exhibitions\u003c\/td\u003e\n        \u003ctd\u003eBIO International Convention (2022)\u003c\/td\u003e\n        \u003ctd\u003e$50,000\u003c\/td\u003e\n        \u003ctd\u003e15,000 attendees\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eScientific Publications\u003c\/td\u003e\n        \u003ctd\u003eAvg. publication fee\u003c\/td\u003e\n        \u003ctd\u003e$2,500 - $5,000\u003c\/td\u003e\n        \u003ctd\u003e10 articles with \u0026gt;150 citations\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eAcademic Collaboration\u003c\/td\u003e\n        \u003ctd\u003eNanjing University partnership\u003c\/td\u003e\n        \u003ctd\u003e$200,000 annually\u003c\/td\u003e\n        \u003ctd\u003eJoint publications and R\u0026amp;D\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eDigital Marketing\u003c\/td\u003e\n        \u003ctd\u003eSEO, PPC, Content Marketing\u003c\/td\u003e\n        \u003ctd\u003e$300,000\u003c\/td\u003e\n        \u003ctd\u003e25% increase in traffic\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003ePharmaBlock Sciences (Nanjing), Inc. - Marketing Mix: Price\u003c\/h2\u003e\n\nCompetitive pricing strategy  \nPharmaBlock Sciences employs a competitive pricing strategy, primarily aimed at aligning its product prices with market standards while ensuring a sustainable profit margin. For instance, the average price for their active pharmaceutical ingredients (APIs) varies between $300 to $1,200 per kilogram, depending on the complexity and scale of the synthesis involved. This pricing model is designed to attract pharmaceutical manufacturers looking for cost-effective solutions.\n\nTiered pricing for bulk orders  \nPharmaBlock offers tiered pricing structures to incentivize bulk purchases. For instance, a customer ordering between 10-50 kg of a specific API may receive a 10% discount, while orders exceeding 50 kg could qualify for a 20% discount. This strategy not only helps in reducing customer acquisition costs but also stabilizes revenue through larger order volumes.\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eOrder Quantity (kg)\u003c\/th\u003e\n\u003cth\u003eBase Price (per kg)\u003c\/th\u003e\n\u003cth\u003eDiscount (%)\u003c\/th\u003e\n\u003cth\u003ePrice after Discount (per kg)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10-50\u003c\/td\u003e\n\u003ctd\u003e$1,000\u003c\/td\u003e\n\u003ctd\u003e10\u003c\/td\u003e\n\u003ctd\u003e$900\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e51-100\u003c\/td\u003e\n\u003ctd\u003e$1,000\u003c\/td\u003e\n\u003ctd\u003e20\u003c\/td\u003e\n\u003ctd\u003e$800\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e101+\u003c\/td\u003e\n\u003ctd\u003e$1,000\u003c\/td\u003e\n\u003ctd\u003e30\u003c\/td\u003e\n\u003ctd\u003e$700\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\nFlexible pricing for long-term contracts  \nPharmaBlock is known for its flexible pricing options in long-term contracts. Clients can negotiate prices that reflect their order volumes and expected duration. For example, a three-year contract for a consistent supply of an API might start at $900 per kg, with a potential reduction of up to 15% if minimum order quantities are met consistently throughout the contract period.\n\nDiscounted rates for research institutions  \nTo encourage collaboration with research institutions, PharmaBlock provides discounted rates. Typically, academic and research institutions receive a discount ranging from 15% to 25% on standard pricing. For instance, a typical API priced at $1,000 per kg may see prices drop to as low as $750 per kg for funded research projects.\n\nCustomized pricing for complex projects  \nPharmaBlock also implements a customized pricing approach for complex or specialized projects. These projects often involve R\u0026amp;D investments and longer development cycles. Pricing is typically determined through a thorough analysis of project scope and requirements. For example, a custom synthesis project might start at an estimated $50,000, with actual prices being contingent on the project’s specific needs and regulatory requirements.\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eProject Type\u003c\/th\u003e\n\u003cth\u003eStarting Price\u003c\/th\u003e\n\u003cth\u003eAverage Duration (months)\u003c\/th\u003e\n\u003cth\u003ePotential Variance (%)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStandard API Synthesis\u003c\/td\u003e\n\u003ctd\u003e$50,000\u003c\/td\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003e20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComplex Custom Synthesis\u003c\/td\u003e\n\u003ctd\u003e$100,000\u003c\/td\u003e\n\u003ctd\u003e12\u003c\/td\u003e\n\u003ctd\u003e30\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsultation \u0026amp; Advisory Services\u003c\/td\u003e\n\u003ctd\u003e$30,000\u003c\/td\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003e10\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003cp\u003eIn conclusion, PharmaBlock Sciences (Nanjing), Inc. stands out in the competitive pharmaceutical landscape through its strategic marketing mix, seamlessly integrating innovative products, a robust global presence, dynamic promotional efforts, and flexible pricing models. By leveraging custom synthesis services, an expansive distribution network, and targeted marketing campaigns, PharmaBlock not only meets the diverse needs of its clientele but also fortifies its position as a leader in drug discovery and development. This holistic approach ensures that PharmaBlock remains at the forefront of the industry, driving both growth and innovation in a rapidly evolving market.\u003c\/p\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45679847866517,"sku":"300725sz-marketing-mix","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/300725sz-marketing-mix.png?v=1739127326","url":"https:\/\/dcf-model.com\/fr\/products\/300725sz-marketing-mix","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}